Minireviews
Copyright ©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 95987
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95987
Table 1 Possible proposal of acceptable liver donors with history of or current genitourinary malignancy (adapted from[15])
Minimal risk
Low to intermediate risk
High risk
Unacceptable risk
Current
NMIBC – in situ and T1Prostate cancer-Gleason score 7Prostate cancer- Gleason score >7Metastatic prostate cancer
Prostate cancer - Gleason score ≤ 6RCC 1-4 cm and Fuhrman grade I/II RCC > 7 cm and Fuhrman grade III/IVRCC stages T3/T4
RCC < 1 cm and Fuhrman grade I/IIRCC 4-7 cm and Fuhrman grade I/II MIBC – post chemoradiation
History
Prostate cancer Gleason up to 6 Prostate cancer Gleason = 7 after curative treatment and cancer-free period > 5 yrRCC 1-4 cm, FG I/II; RCC 4-7 cm, FG I/IIProstate cancer with extraprostatic spreadAny metastatic genitourinary malignancy
RCC < 1 cm and FG I/IIRCC > 7 cm and FG III/IVRCC stages T3/T4